Adam Kaye

Professor

University of the Pacific

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Adam Kaye is a Professor at the University of the Pacific, USA. His research interests encompass various aspects of pharmacology and clinical management, with a focus on recent developments in treating cardiac arrhythmias, post-transplant patient care, and hypertension. He has also contributed to understanding the implications of COVID-19 on addiction treatment and pain management strategies using emerging therapies.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Kevin S. Murnane

UNITED STATES

View details

Alan D. Kaye

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adam Kaye

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Macrolide Antibiotic Mediated Cardiac Arrhythmias: Emerging Concepts and Clinical Implications

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations

Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients

Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs

Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children

Transcranial Stimulation for the Treatment of Stimulant Use Disorder

Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects

Prescription Stimulants in College and Medical Students: A Narrative Review of Misuse, Cognitive Impact, and Adverse Effects

Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence

Addiction and COVID: Issues, Challenges, and New Telehealth Approaches

Neurological and Psychiatric Symptoms of COVID-19: A Narrative Review

Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review

The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease

Collaborators (2)

Kevin S. Murnane

Alan D. Kaye

Make your next move.

Adam Kaye

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Macrolide Antibiotic Mediated Cardiac Arrhythmias: Emerging Concepts and Clinical Implications

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations

Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients

Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs

Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children

Transcranial Stimulation for the Treatment of Stimulant Use Disorder

Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects

Prescription Stimulants in College and Medical Students: A Narrative Review of Misuse, Cognitive Impact, and Adverse Effects

Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence

Addiction and COVID: Issues, Challenges, and New Telehealth Approaches

Neurological and Psychiatric Symptoms of COVID-19: A Narrative Review

Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review

The Possible Application of Ketamine in the Treatment of Depression in Alzheimer&rsquo;s Disease

Collaborators (2)

Kevin S. Murnane

Alan D. Kaye

Make your next move.

The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease